Join to View Full Profile
5841 S Maryland AveChicago, IL 60637
Phone+1 773-834-2473
Fax+1 773-702-9082
Dr. Charnot-Katsikas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Molecular Genetic Pathology, 2019 - 2020- University of Chicago Medical CenterClinical Medical Ethics (MacLean Center), 2019 - 2020
- University of ChicagoFellowship, Medical Microbiology, 2011 - 2013
- University of ChicagoResidency, Pathology-Anatomic and Clinical, 2006 - 2009
Rush Medical College of Rush University Medical CenterClass of 2005
Certifications & Licensure
IL State Medical License 2008 - 2026
American Board of Pathology Pathology - Clinical- American Board of Pathology Pathology - Medical Microbiology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 78 citationsEpidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collab...Feixue Wei, Michael M. Gaisa, Gypsyamber D'Souza, Ningshao Xia, Anna R. Giuliano
The Lancet. HIV. 2021-07-30 - 3 citationsFrom Etest to Vitek 2: Impact of Enterococcal Linezolid Susceptibility Testing Methodology on Time to Active Therapy.Cynthia T Nguyen, Cindy Bethel, Natasha N Pettit, Angella Charnot-Katsikas
Antimicrobial Agents and Chemotherapy. 2020-08-20 - 30 citationsClinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.Anand Patel, Kirk E. Cahill, Angella Charnot-Katsikas, Hongtao Liu, Sandeep Gurbuxani
British Journal of Haematology. 2020-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
